SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADGI - American Diversified Group -- Ignore unavailable to you. Want to Upgrade?


To: Jamessmith who wrote (4835)2/26/1998 12:14:00 PM
From: Dean  Read Replies (1) | Respond to of 9569
 
We got News !!



To: Jamessmith who wrote (4835)2/26/1998 12:28:00 PM
From: Bob Mohebbi  Read Replies (1) | Respond to of 9569
 
Company Press Release Thursday February 26, 11:52 am Eastern Time

ADGI Continues Further Shipments to Central Pharmacy of Mali
NEW YORK--(BUSINESS WIRE)--Feb. 26, 1998--American Diversified Group (OTC.BB:ADGI) Thursday announced additional shipments of generic pharmaceutical products to the Central Pharmacy of the Republic of Mali under purchase orders received by ADGI during the third and fourth quarters of fiscal 1997.

Today, ADGI scheduled the shipment one million units of Paracetamol to Mali for Monday, March 2, 1998, from a German manufacturer, pursuant to existing and continuing orders from the Central Pharmacy of Mali.

This follows the shipment to Mali of one million units of Methyldopa from a Dutch manufacturer, as announced by ADGI on Feb. 12, 1998.

For further information, ADGI's Broadcast Fax System will disseminate ADGI information (releases, newsletters, shareholder updates), and is accessible to all ADGI shareholders via fax. To add your fax number to ADGI's Broadcast System, please contact ADGI's NYC Conference Office at 212/332-5009 or by fax at 212/332-3249.

--------------------------------------------------------------------------------
Contact:
American Diversified Group Inc.
Dr. Jerrold R. Hinton, 212/332-5009

--------------------------------------------------------------------------------